Global Virus-like Particle Vaccine Market Size

Global Virus-like Particle Vaccine Market Size

GlobeNewswire

Published

Key players operating in the global virus-like particle vaccine market include Novavax, GlaxoSmithKline, Merck & Co., Medicago, Dynavax Technologies, Cytos Biotechnology, iBio, Sanofi Pasteur, Bavarian Nordic, and GeoVax Labs, among others.

Brooklyn, New York, Oct. 09, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the *global virus-like particle vaccine market* is expected to grow at a CAGR of 7.8% from 2023 to 2028.Advances in biotechnology, such as genetic engineering and protein expression technologies, have made it more cost-effective and efficient to produce VLPs. This has reduced barriers to entry for vaccine development.

*Key Market Insights*

· As per the stage outlook, the approved vaccines segment is expected to be the largest segment during the forecast period
· As per the application type outlook, the infectious disease segment is projected to be the largest segment during the forecast period
· Asia Pacific region is analyzed to be the fastest-growing region in the market
· North America region is analyzed to account for largest share in the global market during the forecast period of 2023-2028
· Key players operating in the global virus-like particle vaccine market include Novavax, GlaxoSmithKline, Merck & Co., Medicago, Dynavax Technologies, Cytos Biotechnology, iBio, Sanofi Pasteur, Bavarian Nordic, and GeoVax Labs, among others
*Request for a Sample Copy of the Report: **https://www.globalmarketestimates.com/market-report/virus-like-particle-vaccine-market-4186*

*By Distribution Channel* *(Revenue, USD Billion, 2023-2028) *

· Healthcare Providers
· Retail Pharmacies
· Government Vaccination Programs
*By Stage (Revenue, USD Billion, 2023-2028)*

· Pre-clinical Research Stage
· Approved Vaccines

*By Application Type (Revenue, USD Billion, 2023-2028)*

· Infectious Diseases
· Cancer Immunotherapy
· Others
*By Regional Outlook (Revenue, USD Billion, 2023-2028)*

*North America*        

· U.S.
· Canada
· Mexico
*Europe*

· Germany
· U.K.
· France
· Spain
· Italy
· Netherlands
· Rest of Europe
*Asia Pacific*

· China
· India
· Japan
· South Korea
· Thailand
· Indonesia
· Malaysia
· Singapore
· Vietnam
· Rest of APAC

*Central and South America*

· Brazil
· Argentina
· Chile
· Rest of CSA

*Middle East and Africa*

· Saudi Arabia
· UAE
· Israel
· South Africa
· Rest of MEA
*Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and in-depth TOC on “**Global Virus-Like Particle Vaccine Market - Forecast to 2028**’’ *

*
*

*Contact: Yash Jain*

*Director - Global Accounts & Strategic Advisory*

*Email address: **yash.jain@globalmarketestimates.com*

*Phone Number: +1 6026667238*

*LinkedIn: **https://www.linkedin.com/in/yash-jain-global-market-estimates/*

*Website: **www.globalmarketestimates.com*

*Attachment*

· Global Virus-like Particle Vaccine Market Size

CONTACT: Contact: Yash Jain

Director - Global Accounts & Strategic Advisory

Email address: yash.jain@globalmarketestimates.com

Phone Number: +1 6026667238

LinkedIn: https://www.linkedin.com/in/yash-jain-global-market-estimates/

Website: www.globalmarketestimates.com

Full Article